ATLANTA, GA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
A new malaria vaccine achieves an unparalleled 89% efficacy by targeting late-liver-stage antigens, unlocking new horizons in the fight against global disease. Study: Safety and Efficacy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback